Skip to main content
letter
. 2015 Nov 6;10(3):371–372. doi: 10.1093/ecco-jcc/jjv206

Figure 1.

Figure 1.

Kaplan–Meier survival curve of the proportion of patients without relapse after de-escalation of infliximab (IFX) maintenance therapy from an 8- to a 10-week dosing interval based on serial faecal calprotectin measurements in Crohn’s disease patients with composite deep remission. w, weeks.